SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Qiu-Zhong Pan, Qi-Jing Wang, Jia-Qiang Dan, Ke Pan, Yong-Qiang Li, Yao-Jun Zhang, Jing-Jing Zhao, De-Sheng Weng, Yan Tang, Li-Xi Huang, Jia He, Shi-Ping Chen, Miao-La Ke, Min-Shan Chen, Max S. Wicha, Alfred E. Chang, Yi-Xin Zeng, Qiao Li, Jian-Chuan Xia, A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma, Scientific Reports, 2015, 5, 9202

    CrossRef

  2. 2
    Jing-Jun Yan, Jia-Zhi Liao, Ju-Sheng Lin, Xing-Xing He, Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems, Tumor Biology, 2015, 36, 1, 55

    CrossRef

  3. 3
    Qiu-Zhong Pan, Ke Pan, Qi-Jing Wang, De-Sheng Weng, Jing-Jing Zhao, Hai-Xia Zheng, Xiao-Fei Zhang, Shan-Shan Jiang, Lin Lv, Yan Tang, Yong-Qiang Li, Jia He, Qing Liu, Chang-Long Chen, Hong-Xia Zhang, Jian-Chuan Xia, Annexin A3 as a Potential Target for Immunotherapy of Liver Cancer Stem-Like Cells, STEM CELLS, 2015, 33, 2
  4. 4
    Yanhong Xu, An Xiao, Jia Yang, Zaixian Zhang, Guixiang Zhang, Assessment of Lipiodol Deposition and Residual Cancer for HCC After TACE via Iodine-Based Material Decomposition Images With Spectral CT Imaging: A Preliminary Study, Iranian Journal of Radiology, 2015, 12, 2

    CrossRef

  5. 5
    Jie-Yi Shi, Liu-Xiao Yang, Zhi-Chao Wang, Ling-Yan Wang, Jian Zhou, Xiao-Ying Wang, Guo-Ming Shi, Zhen-Bin Ding, Ai-Wu Ke, Zhi Dai, Shuang-Jian Qiu, Qi-Qun Tang, Qiang Gao, Jia Fan, CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma, The Journal of Pathology, 2015, 235, 4
  6. 6
    Federico Collettini, Nadja Schreiber, Dirk Schnapauff, Timm Denecke, Peter Wust, Eckart Schott, Bernd Hamm, Bernhard Gebauer, CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma, Strahlentherapie und Onkologie, 2015, 191, 5, 405

    CrossRef

  7. 7
    Tianxiang Ge, Qiujin Shen, Ning Wang, Yurong Zhang, Zhouhong Ge, Wei Chu, Xiufang Lv, Fengbo Zhao, Weifeng Zhao, Jia Fan, Wenxin Qin, Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma, Medical Oncology, 2015, 32, 3

    CrossRef

  8. 8
    Shi-Yan Zhang, Bi-Ding Lin, Bu-Ren Li, Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma, FEBS Open Bio, 2015, 5, 240

    CrossRef

  9. 9
    Hua-Xing Ma, Qing-Hua Shu, Jing-Jing Pan, Dong Liu, Ge-Liang Xu, Jian-Sheng Li, Jin-Liang Ma, Wei-Dong Jia, Ji-Hai Yv, Yong-Sheng Ge, Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance, Tumor Biology, 2015,

    CrossRef

  10. 10
    Hong Zeng, Lei-bo Xu, Jian-ming Wen, Rui Zhang, Man-sheng Zhu, Xiang-de Shi, Chao Liu, Hepatocellular Carcinoma With Bile Duct Tumor Thrombus, Medicine, 2015, 94, 1, e364

    CrossRef

  11. 11
    Seung-Ho Heo, Eui-Suk Jeong, Kyoung-Sun Lee, Jin-Hee Seo, Woon-Kyu Lee, Yang-Kyu Choi, Kr�ppel-like factor 10 null mice exhibit lower tumor incidence and suppressed cellular proliferation activity following chemically induced liver tumorigenesis, Oncology Reports, 2015,

    CrossRef

  12. 12
    Wei Peng, Hong Fan, Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma, Biomedicine & Pharmacotherapy, 2015,

    CrossRef

  13. 13
    C. Pilapong, C. Raiputta, J. Chaisupa, S. Sittichai, S. Thongtem, T. Thongtem, Magnetic-EpCAM nanoprobe as a new platform for efficient targeting, isolating and imaging hepatocellular carcinoma, RSC Adv., 2015, 5, 39, 30687

    CrossRef

  14. 14
    Song He, De-Chun Zhang, Cheng Wei, MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis, Clinics and Research in Hepatology and Gastroenterology, 2015,

    CrossRef

  15. 15
    Tao Han, Dai-Min Xiang, Wen Sun, Na Liu, Huan-Lin Sun, Wen Wen, Wei-Feng Shen, Ruo-Yu Wang, Cheng Chen, Xue Wang, Zhuo Cheng, Heng-Yu Li, Meng-Chao Wu, Wen-Ming Cong, Gen-Sheng Feng, Jin Ding, Hong-Yang Wang, PTPN11/Shp2 Overexpression Enhances Liver Cancer Progression and Predicts Poor Prognosis of Patients, Journal of Hepatology, 2015,

    CrossRef

  16. 16
    Monika Zochowska, Anne-Christine Piguet, Jacek Jemielity, Joanna Kowalska, Ewa Szolajska, Jean-François Dufour, Jadwiga Chroboczek, Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma, Nanomedicine: Nanotechnology, Biology and Medicine, 2015, 11, 1, 67

    CrossRef

  17. 17
    Jin-xing Wei, Li-hong Lv, Yun-le Wan, Yang Cao, Guo-lin Li, Hao-ming Lin, Rui Zhou, Chang-zhen Shang, Jun Cao, Hai He, Qing-fang Han, Pei-qing Liu, Gang Zhou, Jun Min, Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells, Hepatology, 2015, 61, 4
  18. 18
    Shuli Man, Wei Fan, Zhen Liu, Wenyuan Gao, Yuanyuan Li, Liming Zhang, ChangXiao Liu, Antitumor pathway of Rhizoma Paridis Saponins based on the metabolic regulatory network alterations in H22 hepatocarcinoma mice, Steroids, 2014, 84, 17

    CrossRef

  19. 19
    Karen L. Morris, Jonathan D. Tugwood, Leila Khoja, Matthew Lancashire, Robert Sloane, Debbie Burt, Patrick Shenjere, Cong Zhou, Clare Hodgson, Toshihiko Ohtomo, Atsuhiko Katoh, Takahiro Ishiguro, Juan W. Valle, Caroline Dive, Circulating biomarkers in hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology, 2014, 74, 2, 323

    CrossRef

  20. 20
    Tao Li, Lun-Xiu Qin, Xiao Gong, Jian Zhou, Hui-Chuan Sun, Lu Wang, Shuang-Jian Qiu, Qing-Hai Ye, Jia Fan, Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma, Surgery, 2014, 156, 3, 651

    CrossRef

  21. 21
    Jia-Hao Jiang, Yan-Feng Liu, Ai-Wu Ke, Fang-Ming Gu, Yao Yu, Zhi Dai, Qiang Gao, Guo-Ming Shi, Bo-Yi Liao, You-Hua Xie, Jia Fan, Xiao-Wu Huang, Jian Zhou, Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing, Hepatology, 2014, 59, 6
  22. 22
    Jingxiang Shi, Quan Sun, Yijun Wang, Xiang Jing, Jianmin Ding, Qiang Yuan, Chaoyi Ren, Shigang Shan, Yandong Wang, Zhi Du, Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria, Journal of Gastroenterology and Hepatology, 2014, 29, 7
  23. 23
    Fa-Da Xia, Zhuo-Lu Wang, Hong-Xi Chen, Yun Huang, Jin-Dong Li, Zhi-Ming Wang, Xin-Ying Li, Differential Expression of IQGAP1/2 in Hepatocellular Carcinoma and its Relationship with Clinical Outcomes, Asian Pacific Journal of Cancer Prevention, 2014, 15, 12, 4951

    CrossRef

  24. 24
    Lorenzo Fornaro, Caterina Vivaldi, Chiara Caparello, Rodolfo Sacco, Virginia Rotella, Gianna Musettini, Sauro Luchi, Edi Editta Baldini, Alfredo Falcone, Gianluca Masi, Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapy, Future Oncology, 2014, 10, 2, 285

    CrossRef

  25. 25
    Victor Au, Felice H Tsang, Kwan Man, Sheung Tat Fan, Ronnie TP Poon, Nikki P Lee, Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells, BioScience Trends, 2014, 8, 2, 101

    CrossRef

  26. 26
    Wei-Ren Liu, Meng-Xin Tian, Lei Jin, Liu-Xiao Yang, Zhen-Bin Ding, Ying-Hao Shen, Yuan-Fei Peng, Jian Zhou, Shuang-Jian Qiu, Zhi Dai, Jia Fan, Ying-Hong Shi, High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma, Journal of Experimental & Clinical Cancer Research, 2014, 33, 1, 32

    CrossRef

  27. 27
    Gizachew Yismaw Wubetu, Tohru Utsunomiya, Daichi Ishikawa, Shinichiro Yamada, Tetsuya Ikemoto, Yuji Morine, Shuichi Iwahashi, Yu Saito, Yusuke Arakawa, Satoru Imura, Mami Kanamoto, Chengzhan Zhu, Yoshimi Bando, Mitsuo Shimada, High STAT4 Expression is a Better Prognostic Indicator in Patients with Hepatocellular Carcinoma After Hepatectomy, Annals of Surgical Oncology, 2014, 21, S4, 721

    CrossRef

  28. 28
    Ruoyu Miao, Haitao Luo, Huandi Zhou, Guangbing Li, Dechao Bu, Xiaobo Yang, Xue Zhao, Haohai Zhang, Song Liu, Ying Zhong, Zhen Zou, Yan Zhao, Kuntao Yu, Lian He, Xinting Sang, Shouxian Zhong, Jiefu Huang, Yan Wu, Rebecca A. Miksad, Simon C. Robson, Chengyu Jiang, Yi Zhao, Haitao Zhao, Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis, Journal of Hepatology, 2014, 61, 4, 840

    CrossRef

  29. 29
    Yong-Gang Yao, IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma, Medical Science Monitor, 2014, 20, 247

    CrossRef

  30. 30
    Karen Kaiser, Rajiv Mallick, Zeeshan Butt, Mary F. Mulcahy, Al B. Benson, David Cella, Important and relevant symptoms including pain concerns in hepatocellular carcinoma (HCC): a patient interview study, Supportive Care in Cancer, 2014, 22, 4, 919

    CrossRef

  31. 31
    Feng Li, Yu-Chen Fan, Shuai Gao, Feng-Kai Sun, Yang Yang, Kai Wang, Methylation of serum insulin-like growth factor-binding protein 7 promoter in hepatitis B virus-associated hepatocellular carcinoma, Genes, Chromosomes and Cancer, 2014, 53, 1
  32. 32
    Heng-Jun Gao, Ming-Chi Zhao, Yao-Jun Zhang, Dong-Sheng Zhou, Li Xu, Guang-Bing Li, Min-Shan Chen, Jun Liu, Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration, Journal of Cancer Research and Clinical Oncology, 2014,

    CrossRef

  33. 33
    Kai Wei, Meng Wang, Wei Zhang, Han Mu, Tian-Qiang Song, Neutrophil–lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib, Medical Oncology, 2014, 31, 6

    CrossRef

  34. 34
    Daishun Ling, Hongping Xia, Wooram Park, Michael J. Hackett, Changyeong Song, Kun Na, Kam Man Hui, Taeghwan Hyeon, pH-Sensitive Nanoformulated Triptolide as a Targeted Therapeutic Strategy for Hepatocellular Carcinoma, ACS Nano, 2014, 8, 8, 8027

    CrossRef

  35. 35
    Ke Zhang, Li Jiang, Rong He, Bao-Liang Li, Zhe Jia, Rong-Hai Huang, Yi Mu, Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma, Tumor Biology, 2014, 35, 8, 7669

    CrossRef

  36. 36
    Xuyong Wei, Jie Li, Haiyang Xie, Qi Ling, Jianguo Wang, Di Lu, Lin Zhou, Xiao Xu, Shusen Zheng, Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma, Cancer Letters, 2014, 351, 1, 117

    CrossRef

  37. 37
    Chaohui Zuo, Man Xia, Qunfeng Wu, Haizhen Zhu, Jingshi Liu, Chen Liu, Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review), Oncology Letters, 2014,

    CrossRef

  38. 38
    Xibo Ma, Zhen Cheng, Yushen Jin, Xiaolong Liang, Xin Yang, Zhifei Dai, Jie Tian, SM5-1-Conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy, Biomaterials, 2014, 35, 9, 2878

    CrossRef

  39. 39
    Shaihana Abdulrahman Almatrrouk, Anthony W Oliver, Lynne Hampson, Ian N Hampson, Targeting gap junction intercellular communication as a potential therapy for HCV-related carcinogenesis, Future Virology, 2014, 9, 7, 679

    CrossRef

  40. 40
    Z Chen, Z Wang, W Guo, Z Zhang, F Zhao, Y Zhao, D Jia, J Ding, H Wang, M Yao, X He, TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma, Oncogene, 2014,

    CrossRef

  41. 41
    X. Xu, K. Qu, Y. Wan, S. Song, Z. Huang, Z. Wang, C. Liu, Tumor Existence and Tumor Size as Prognostic Factors in Hepatitis B Virus–Related Cirrhosis Patients Who Underwent Liver Transplantation, Transplantation Proceedings, 2014, 46, 5, 1389

    CrossRef

  42. 42
    Zhi-Jun Dai, Wei Tang, Wang-Feng Lu, Jie Gao, Hua-Feng Kang, Xiao-Bin Ma, Wei-Li Min, Xi-Jing Wang, Wen-Ying Wu, Antiproliferative and apoptotic effects of β-elemene on human hepatoma HepG2 cells, Cancer Cell International, 2013, 13, 1, 27

    CrossRef

  43. 43
    Sheng-ran Liang, Guang-rui Hu, Li-juan Fang, Su-jing Huang, Jin-song Li, Ming-yi Zhao, Min-jie Meng, CpG oligodeoxynucleotides enhance chemosensitivity of 5-fluorouracil in HepG2 human hepatoma cells via downregulation of the antiapoptotic factors survivin and livin, Cancer Cell International, 2013, 13, 1, 106

    CrossRef

  44. 44
    H.-Y. Chen, Y.-L. Hou, X.-M. Ma, H.-Y. Xie, M. Ye, Y.-R. Bai, CT and MRI in target delineation in primary hepatocellular carcinoma, Cancer/Radiothérapie, 2013, 17, 8, 750

    CrossRef

  45. 45
    H.-y. Chen, X.-m. Ma, M. Ye, Y.-l. Hou, B. Hu, Y.-r. Bai, CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation, Journal of Radiation Research, 2013, 54, 5, 938

    CrossRef

  46. 46
    Yan-feng Pan, Tao Qin, Lei Feng, Zu-jiang Yu, Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma, Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, 33, 1, 96

    CrossRef

  47. 47
    Shuying Dong, Jian Kong, Fandong Kong, Jinge Kong, Jun Gao, Shan Ke, Shaohong Wang, Xuemei Ding, Wenbing Sun, Lemin Zheng, Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways, Journal of Translational Medicine, 2013, 11, 1, 273

    CrossRef

  48. 48
    Peter Schirmacher, Diego F. Calvisi, Molecular Diagnostic Algorithms in Hepatocellular Carcinoma: Dead-End Street or Light at the End of the Tunnel?, Gastroenterology, 2013, 145, 1, 49

    CrossRef

  49. 49
    Feng-Ze Wang, Peng-Jiao, Na-Na Yang, Chuang-Yuan, Ya-Li Zhao, Qiang-Qiang Liu, Hong-Rong Fei, Ji-Guo Zhang, PF-04691502 triggers cell cycle arrest, apoptosis and inhibits the angiogenesis in hepatocellular carcinoma cells, Toxicology Letters, 2013, 220, 2, 150

    CrossRef

  50. 50
    Lu He, Xinke Zhou, Chen Qu, Yunqiang Tang, Qiong Zhang, Jian Hong, Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients, Medical Oncology, 2013, 30, 4

    CrossRef

  51. 51
    Zhidong Wang, Jun Li, Yuanyuan Ji, Peng An, Shu Zhang, Zongfang Li, Traditional Herbal Medicine: A Review of Potential of Inhibitory Hepatocellular Carcinoma in Basic Research and Clinical Trial, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef